| Description | ACAD10 Human Pre-designed siRNA Set A contains three designed siRNAs for ACAD10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components ACAD10 siRNA-1: 5 nmol (HPLC) ACAD10 siRNA-2: 5 nmol (HPLC) ACAD10 siRNA-3: 5 nmol (HPLC) siRNA Negative ACAD10 Human Pre-designed siRNA Set A contains three designed siRNAs for ACAD10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components ACAD10 siRNA-1: 5 nmol (HPLC) ACAD10 siRNA-2: 5 nmol (HPLC) ACAD10 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | Biochemical Test:SDS-PAGE (purity > 80%); Western blot with patient sample.Calculated Isoelectric Point:pH 8.38 | Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months | PTD-p65-P1 Peptide TFA is a potent, selective nuclear transcription factor NF-κB inhibitor and derives from the p65 subunit of NF-κB amino acid residues 271-282, which selectively inhibits NF-κB activation induced by various inflammatory stimulation, downAppearance:SolidIC50& PTD-p65-P1 Peptide TFA is a potent, selective nuclear transcription factor NF-κB inhibitor and derives from the p65 subunit of NF-κB amino acid residues 271-282, which selectively inhibits NF-κB activation induced by various inflammatory stimulation, downAppearance:SolidIC50& Target:NF-kappaBIn Vitro:PTD-p65-P1 Peptide TFA (10-150 µM; 0-60 min; KBM-5 cells) inhibits TNF-induced NF-κB activation in a dose-dependent manner and suppresses TNF-induced NF-κB activation by 25% at 100 µM and completely at 150 µM. PTD-p65-P1 Peptide TFA (150 µM; 0-60 minBiological Activity:PTD-p65-P1 Peptide TFA is a potent, selective nuclear transcription factor NF-κB inhibitor and derives from the p65 subunit of NF-κB amino acid residues 271-282, which selectively inhibits NF-κB activation induced by various inflammatory stimulation, down... Read More | Inquire |